Quarterly Result2 May 2026, 04:11 pm
Epigral Ltd Approves Audited Financial Results for FY26
AI Summary
Epigral Ltd's Board of Directors approved the audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026, in a meeting held on May 2, 2026. The board also approved the audit report issued by M/s. S R B C & CO LLP with an unmodified opinion. A final dividend of ₹5.00 (50%) per equity share of face value ₹10 each was recommended for the financial year 2025-26.
Key Highlights
- Audited financial results (standalone & consolidated) for FY26 approved.
- Audit report by M/s. S R B C & CO LLP issued with unmodified opinion.
- Final dividend of ₹5.00 (50%) per share recommended for FY26.
- Board meeting was held on May 2, 2026.
Price Impact
More from MFL